Outpace Bio

Outpace Bio

Biotechnology, 700 Dexter Ave N, Seattle, Washington, 98109, United States, 51-200 Employees

outpacebio.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 16*********

Who is OUTPACE BIO

Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that ...

Read More

map
  • 700 Dexter Ave N, Seattle, Washington, 98109, United States Headquarters: 700 Dexter Ave N, Seattle, Washington, 98109, United States
  • 2020 Date Founded: 2020
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies
  • Marc Lajoie CEO:   Marc Lajoie

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from OUTPACE BIO

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Outpace Bio

Answer: Outpace Bio's headquarters are located at 700 Dexter Ave N, Seattle, Washington, 98109, United States

Answer: Outpace Bio's phone number is 16*********

Answer: Outpace Bio's official website is https://outpacebio.com

Answer: Outpace Bio's revenue is $10 Million to $25 Million

Answer: Outpace Bio's SIC: 2836

Answer: Outpace Bio's NAICS: 541714

Answer: Outpace Bio has 51-200 employees

Answer: Outpace Bio is in Biotechnology

Answer: Outpace Bio contact info: Phone number: 16********* Website: https://outpacebio.com

Answer: Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpaces suite of technologies drive persistent activity of the cell therapy (OutLastTM), recruit a productive immune response in the tumor microenvironment (OutSmartTM), and achieve the potency (OutSpacersTM), specificity (Co-LOCKRTM), and safety (EGFRoptTM) necessary to unlock diverse cancer indications. Outpaces internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes. At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access